1. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents;DAPT Study Investigators;N Engl J Med,2014
2. Long-term use of ticagrelor in patients with prior myocardial infarction;PEGASUS-TIMI 54 Steering Committee and Investigators;N Engl J Med,2015
3. Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients;Eur Heart J,2017
4. Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials;Eur Heart J,2016
5. Benefits and risks of extended duration dual antiplatelet therapy after PCI in patients with and without acute myocardial infarction;DAPT Study Investigators;J Am Coll Cardiol,2015